U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula 2C3H5O3.Mg
Molecular Weight 202.445
Optical Activity ( + / - )
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MAGNESIUM LACTATE

SMILES

[Mg++].CC(O)C([O-])=O.CC(O)C([O-])=O

InChI

InChIKey=OVGXLJDWSLQDRT-UHFFFAOYSA-L
InChI=1S/2C3H6O3.Mg/c2*1-2(4)3(5)6;/h2*2,4H,1H3,(H,5,6);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula Mg
Molecular Weight 24.305
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C3H5O3
Molecular Weight 89.07
Charge -1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Magnesium diamide is used as a chemical intermediate. Magnesium diamide is spontaneously combustible. It is toxic by inhalation. Skin or eye contact may cause severe burns.

Originator

Curator's Comment: Ulex, a Swedish geologist, is generally credited with introduction of the term struvite in1845

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Preventing
MAGNESIUM SULFATE

Approved Use

INDICATIONS AND USAGE Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.

Launch Date

1995
Primary
MAGNESIUM SULFATE

Approved Use

INDICATIONS AND USAGE Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.

Launch Date

1995
Diagnostic
ColPrep Kit

Approved Use

INDICATIONS AND USAGE ColPrep Kit is indicated for cleansing of the colon as a preparation for colonoscopy in adults

Launch Date

2016
Primary
MAGNESIUM SULFATE

Approved Use

INDICATIONS AND USAGE Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.

Launch Date

1995
Curative
MagMin

Approved Use

Magnesium aspartate (MagMin) is indicated for patients with documented hypomagnesaemia.
Curative
DELBIASE

Approved Use

Unknown
Primary
DELBIASE

Approved Use

Unknown
Primary
DELBIASE

Approved Use

Unknown
Curative
Magnesium Chloride

Approved Use

Magnesium Chloride injection is indicated as an electrolyte replenisher in magnesium deficiencies
Palliative
Magnesium Chloride

Approved Use

Unknown
Palliative
Magnesium Chloride

Approved Use

Unknown
Primary
EPIMAG

Approved Use

Magnesium citrate is indicated in cases of oxaluria, to prevent recurrence of calcium oxalate kidney stones.
Primary
EPIMAG

Approved Use

Used to relief of occasional constipation (irregularity).
Curative
Magnesium Citrate

Approved Use

Magnesium citrate is indicated to supports magnesium nutritional adequacy.
Curative
Unknown

Approved Use

Magnesium lactate is a naturally occurring mineral that is needed in the body to support the function of the heart, nervous system, and digestive system. Magnesium lactate is used as a mineral supplement to treat magnesium deficiency.
PubMed

PubMed

TitleDatePubMed
Metabolic effects of prolonged intravenous administration of magnesium lactate to the normal human.
1958 Sep 23
Struvite stones.
1978 May
Cardiopulmonary arrest due to acute maternal hypermagnesaemia.
1981 May 9
[Inhibitory effect of magnesium on the vocalization and fighting of cats treated with carbachol and eserine].
1982
Hypomagnesaemic tetany associated with prolonged treatment with aminoglycosides.
1986 Mar 22
Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects.
1986 Nov
Metabolism of magnesium and zinc in patients treated with antiepileptic drugs and with magnesium lactate.
1987
A comparison of two digestion procedures for the determination of selenium in biological material.
1987 Oct
Fluorimetry of selenium in body fluids after digestion with nitric acid, magnesium nitrate hexahydrate, and hydrochloric acid.
1988 Sep
Magnesium and its combination with cinnarizine in the long-term treatment of headache.
1991
Osteoporosis treated with magnesium lactate.
1991
Oral versus intravenous magnesium supplementation in patients with magnesium deficiency.
1991-1992
Management of eclampsia.
1994 Apr
A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction.
1994 Dec
Accidental cardiopulmonary arrest following magnesium sulphate overdose.
1994 Jun 15
Effect of pyridoxine and magnesium on stress-induced gastric ulcers in mice selected for low or high blood magnesium levels.
1995
Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity.
1995
Inhibition of mouse-killing behaviour in magnesium-deficient rats: effect of pharmacological doses of magnesium pidolate, magnesium aspartate, magnesium lactate, magnesium gluconate and magnesium chloride.
1995 Mar
Conventional and Eccentric Uses of Crystallographic Databases in Practical Materials Identification Problems.
1996 May-Jun
Magnesium supplementation in patients with congestive heart failure.
1997 Feb
Struvite stones.
1999
Effect of chronic magnesium supplementation on magnesium distribution in healthy volunteers evaluated by 31P-NMRS and ion selective electrodes.
1999 Nov
Some magnesium salts and a mixture of magnesium and calcium salts accelerate skin barrier recovery.
1999 Oct
Trifluoromethanesulfonic anhydride-promoted alpha-bromination of ketones with grignard reagent or magnesium bromide.
2000 Dec
An efficient chiral moderator prepared from inexpensive (+)-3-carene: synthesis of the HIV-1 non-nucleoside reverse transcriptase inhibitor DPC 963.
2000 Oct 5
Bioavailability of US commercial magnesium preparations.
2001 Dec
Magnesium bromide mediated highly diastereoselective heterogeneous hydrogenation of olefins.
2002 Apr 18
Oral magnesium load test in patients with migraine.
2002 Feb
Synthesis of a non-heme template for attaching four peptides: an approach to artificial iron(II)-containing peroxidases.
2004 Jan 23
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence.
2006 Apr
Formation of formal disilene fluoride adducts.
2008 Dec 24
Intradermal administration of magnesium sulphate and magnesium chloride produces hypesthesia to mechanical but hyperalgesia to heat stimuli in humans.
2009 Aug 28
Increased expression of glucose transporter 3 in gerbil brains following magnesium sulfate treatment and focal cerebral ischemic injury.
2010 Jun
Effect of magnesium lactate dihydrate and calcium lactate monohydrate on 20-km cycling time trial performance.
2012 Apr
Magnesium chloride tetrahydrate, MgCl2·4H2O.
2012 Jan
[The effectiveness of certain magnesium salts in nephrolithiasis caused by the use of sodium oxalate and celecoxib].
2013 Jan-Feb
Effects of three kinds of organic acids on phosphorus recovery by magnesium ammonium phosphate (MAP) crystallization from synthetic swine wastewater.
2014 Apr
No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia.
2014 Apr-Jun
A comparison of oral sulfate solution with sodium picosulfate: magnesium citrate in split doses as bowel preparation for colonoscopy.
2014 Dec
Precipitation of amorphous magnesium ammonium phosphate: is it a precursor for staghorn stones?
2014 Jun
Randomized controlled trial of low-volume bowel preparation agents for colonic bowel preparation: 2-L polyethylene glycol with ascorbic acid versus sodium picosulfate with magnesium citrate.
2015 Feb
Single-day sodium picosulfate and magnesium citrate versus split-dose polyethylene glycol for bowel cleansing prior to colonoscopy: A prospective randomized endoscopist-blinded trial.
2015 Nov
Micronized Organic Magnesium Salts Enhance Opioid Analgesia in Rats.
2016
Polyethylene glycol plus ascorbic acid is as effective as sodium picosulfate with magnesium citrate for bowel preparation: A randomized trial.
2016 Apr
Preparation and optimization of a drug delivery system based on berberine chloride-immobilized MgAl hydrotalcite.
2016 Jun 15
Superiority of a Split-dose Regimen of Sodium Picosulfate/Magnesium Citrate (SPMC) in Comparison to a Prior-day Schedule (AM/PM) for Colonoscopy Preparation. A Randomized Single-blinded Study.
2016 Sep
Fast sono assisted ferrofluid mediated silver super - Adsorption over magnesium ferrite-copper sulfide chalcogenide with the aid of multivariate optimization.
2017 Jul
Magnesium lactate in the treatment of Gitelman syndrome: patient-reported outcomes.
2017 Mar 1
Effect of power ultrasound on crystallization characteristics of magnesium ammonium phosphate.
2017 May
Antenatal Exposure to Magnesium Sulfate and Spontaneous Intestinal Perforation and Necrotizing Enterocolitis in Extremely Preterm Neonates.
2017 Oct
Patents

Patents

Sample Use Guides

Magnesium lactate is used as a dietary supplement (200-400 mg of elemental magnesium per day for adults).
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: Magnesium Chloride
Unknown
Substance Class Chemical
Created
by admin
on Wed Apr 02 18:19:44 GMT 2025
Edited
by admin
on Wed Apr 02 18:19:44 GMT 2025
Record UNII
MT6QI8324A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PROMAGSAN
Preferred Name English
MAGNESIUM LACTATE
FCC   INCI   MI   WHO-DD  
INCI  
Official Name English
MAGNESIUM LACTATE, ANHYDROUS
Common Name English
MAGNESIUM DL-LACTATE
Common Name English
MAGNESIUM, BIS(2-HYDROXYPROPANOATO-O1,O2)-, (T-4)-
Common Name English
MAGNESIUM, BIS(LACTATO)-
Common Name English
MAGNESIUM LACTATE, DL-
Common Name English
DL-LACTIC ACID MAGNESIUM SALT
Common Name English
MAGNESIUM LACTATE [MI]
Common Name English
MAGNESIUM LACTATE [FCC]
Common Name English
MAGNESIUM DL(-)-2-HYDROXYPROPIONATE
Common Name English
Magnesium lactate [WHO-DD]
Common Name English
E-329
Common Name English
INS NO.329
Common Name English
MAGNESIUM LACTATE ANHYDROUS
Common Name English
ANHYDROUS MAGNESIUM LACTATE, DL-
Common Name English
INS-329
Common Name English
MAGNESIUM LACTATE, (±)-
Systematic Name English
MAGNESIUM, BIS(2-(HYDROXY-.KAPPA.O)PROPANOATO-.KAPPA.O)-, (T-4)-
Common Name English
Classification Tree Code System Code
WHO-VATC QA12CC06
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
JECFA EVALUATION INS-329
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
WHO-ATC A12CC06
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
CODEX ALIMENTARIUS (GSFA) INS-329
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
Code System Code Type Description
DRUG BANK
DB14515
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
PUBCHEM
5319192
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
SMS_ID
100000089068
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
DRUG CENTRAL
4592
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
GRAS Notification (GRN No.)
570
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
RXCUI
214688
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY RxNorm
WIKIPEDIA
Magnesium lactate
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
EVMPD
SUB14431MIG
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
MERCK INDEX
m7006
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
242-671-4
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
CAS
18917-93-6
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
EPA CompTox
DTXSID20872620
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
FDA UNII
MT6QI8324A
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
ChEMBL
CHEMBL3707281
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
DAILYMED
MT6QI8324A
Created by admin on Wed Apr 02 18:19:44 GMT 2025 , Edited by admin on Wed Apr 02 18:19:44 GMT 2025
PRIMARY
Related Record Type Details
SOLVATE->ANHYDROUS
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY